RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,178 | -8.0% | 19,165 | +37.5% | 0.00% | 0.0% |
| Q2 2023 | $175,124 | -8.6% | 13,943 | +19.9% | 0.00% | 0.0% |
| Q1 2023 | $191,579 | +3.2% | 11,632 | -6.3% | 0.00% | 0.0% |
| Q4 2022 | $185,555 | -19.7% | 12,420 | +20.1% | 0.00% | 0.0% |
| Q3 2022 | $231,000 | +55.0% | 10,345 | +16.3% | 0.00% | 0.0% |
| Q2 2022 | $149,000 | -36.9% | 8,897 | +12.8% | 0.00% | 0.0% |
| Q1 2022 | $236,000 | +50.3% | 7,887 | +54.3% | 0.00% | 0.0% |
| Q4 2021 | $157,000 | +78.4% | 5,112 | +82.6% | 0.00% | – |
| Q3 2021 | $88,000 | – | 2,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |